Advertisement
New Zealand markets closed
  • NZX 50

    11,938.08
    +64.04 (+0.54%)
     
  • NZD/USD

    0.6012
    +0.0049 (+0.83%)
     
  • NZD/EUR

    0.5579
    +0.0023 (+0.42%)
     
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD

    2,310.10
    +0.50 (+0.02%)
     
  • NASDAQ

    17,890.79
    +349.25 (+1.99%)
     
  • FTSE

    8,213.49
    +41.34 (+0.51%)
     
  • Dow Jones

    38,675.68
    +450.02 (+1.18%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • Hang Seng

    18,475.92
    +268.79 (+1.48%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • NZD/JPY

    91.9390
    +0.3640 (+0.40%)
     

New Strong Sell Stocks for July 15th

Here are five stocks added to the Zacks Rank #5 (Strong Sell) List today:

Alphatec Holdings, Inc. ATEC is a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders. The Zacks Consensus Estimate for its current year earnings has been revised 2.6% downward over the last 30 days.

Dicerna Pharmaceuticals, Inc. DRNA is a biopharmaceutical company that focuses on the discovery, development, and commercializing of ribonucleic acid interference (RNAi)-based pharmaceuticals. The Zacks Consensus Estimate for its current year earnings has been revised 5.7% downward over the last 30 days.

First Majestic Silver Corp. AG engages in the acquisition, exploration, development, and production of mineral properties with a focus on silver and gold production. The Zacks Consensus Estimate for its current year earnings has been revised 10.3% downward over the last 30 days.

ADVERTISEMENT

Patria Investments Limited PAX operates as a private market investment firm. The Zacks Consensus Estimate for its current year earnings has been revised 9.3% downward over the last 30 days.

Aurinia Pharmaceuticals Inc. AUPH is a biopharmaceutical company, develops and commercializes therapies to treat various diseases with unmet medical need. The Zacks Consensus Estimate for its current year earnings has been revised 3.4% downward over the last 30 days.

View the entire Zacks Rank #5 List.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alphatec Holdings, Inc. (ATEC) : Free Stock Analysis Report
 
First Majestic Silver Corp. (AG) : Free Stock Analysis Report
 
Dicerna Pharmaceuticals, Inc. (DRNA) : Free Stock Analysis Report
 
Aurinia Pharmaceuticals Inc (AUPH) : Free Stock Analysis Report
 
Patria Investments Limited (PAX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research